Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study-Reference-Cited by-同舟云学术

Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study

Published:2005-02 Issue:9458 Volume:365 Page:475-481
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Graham David J,Campen David,Hui Rita,Spence Michele,Cheetham Craig,Levy Gerald,Shoor Stanford,Ray Wayne A

Publisher

Elsevier BV

Subject

General Medicine

Reference41 articles.

1. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study—a randomized controlled study;Silverstein;JAMA,2000

2. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis;Bombardier;N Engl J Med,2000

3. Risk of cardiovascular events associated with selective COX-2 inhibitors;Mukherjee;JAMA,2001

4. Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program;Weir;Am Heart J,2003

5. Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib;Konstam;Circulation,2001

Cited by 738 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardio-rheumatology: the cardiovascular, pharmacological, and surgical risks associated with rheumatological diseases in women;Canadian Journal of Physiology and Pharmacology;2024-09-01

2. Health Care Fraud and Abuse: Lessons From One of the Largest Scandals of the 21st Century in the Field of Spine Surgery;Annals of Surgery Open;2024-06

3. Cost benefit analysis and the FDA: measuring the costs and benefits of drug approval under the PDUFA I-II, 1998–2005;Journal of Regulatory Economics;2024-04-19

4. High-Throughput Computing to Automate Population-Based Studies to Detect the 30-Day Risk of Adverse Outcomes After New Outpatient Medication Use in Older Adults with Chronic Kidney Disease: A Clinical Research Protocol;Canadian Journal of Kidney Health and Disease;2024-01

5. Heart-on-a-chip systems: disease modeling and drug screening applications;Lab on a Chip;2024